newsfilter
← Latest News
GlobeNewswire·

Oyster Point Pharma Reports Third Quarter 2021 Financial Results and Recent Business Highlights

FDA Approval of TYRVAYA™ (varenicline solution) Nasal Spray for the Treatment of the Signs and Symptoms of Dry Eye Disease on October 15, 2021 Field Force Onboarding Completed During Q3'21, U.S. Launch of TYRVAYA Nasal Spray Initiated on Nov. 1st. TY